Cardiol Therapeutics, Inc. (CRDL)
2.26
+0.04
(+1.80%)
USD |
NASDAQ |
Sep 09, 15:07
Cardiol Therapeutics Debt to Equity Ratio : 0.0045 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0045 |
| March 31, 2026 | 0.0048 |
| December 31, 2025 | 0.007 |
| September 30, 2025 | 0.014 |
| June 30, 2025 | 0.0121 |
| March 31, 2025 | 0.0086 |
| December 31, 2024 | 0.0064 |
| September 30, 2024 | 0.0159 |
| June 30, 2024 | 0.0107 |
| March 31, 2024 | 0.0083 |
| December 31, 2023 | 0.0062 |
| September 30, 2023 | 0.0052 |
| June 30, 2023 | 0.0012 |
| March 31, 2023 | 0.0013 |
| December 31, 2022 | 0.0014 |
| September 30, 2022 | 0.0014 |
| June 30, 2022 | 0.0015 |
| March 31, 2022 | 0.0016 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0015 |
| September 30, 2021 | 0.0044 |
| June 30, 2021 | 0.0041 |
| March 31, 2021 | 0.0081 |
| December 31, 2020 | 0.0118 |
| September 30, 2020 | 0.0074 |
| June 30, 2020 | 0.0067 |
| March 31, 2020 | 0.0146 |
| December 31, 2019 | 0.013 |
| September 30, 2019 | 0.0119 |
| June 30, 2019 | 0.0104 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.0121 |
| September 30, 2018 | -13.07 |
| June 30, 2018 | 10.87 |
| March 31, 2018 | |
| December 31, 2017 | 0.0493 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| InMed Pharmaceuticals, Inc. | 0.061 |
| NervGen Pharma Corp. | 0.00 |
| Milestone Pharmaceuticals, Inc. | 7.785 |
| Clearmind Medicine, Inc. | 0.0075 |
| Lexaria Bioscience Corp. | 0.0183 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 20.69M |
| Total Liabilities (Quarterly) | 3.756M |
| Shareholders Equity (Quarterly) | 16.94M |
| Current Ratio | 5.553 |
| Net Debt Paydown Yield | 0.00% |